Ohio State will lead a $12M NIH-funded trial comparing BiPAP and HFNO to improve emergency respiratory care for patients with acute respiratory failure.
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according ...
A low-cost, widely available drug may offer new hope for patients with severe COVID-19. An international study led by the ...
A $12 million award from National Heart, Lung and Blood Institute (NHLBI) will help researchers at T College of Medicine ...
WASHINGTON (TNND) — Five years after the world essentially shut down in response to the Coronavirus Pandemic, there is still a lot we don’t know about COVID-19. One looming question surrounds one of ...
Air pollution has increased significantly these days, directly impacting lung health. Excessive smoking and unhealthy eating habits are also damaging the lungs. According to health experts, ...